LLY

732.88

+0.07%↑

JNJ

177.5

+0.27%↑

ABBV

211.68

+0.66%↑

UNH

308.79

-0.21%↓

NVO

56.36

-0.23%↓

LLY

732.88

+0.07%↑

JNJ

177.5

+0.27%↑

ABBV

211.68

+0.66%↑

UNH

308.79

-0.21%↓

NVO

56.36

-0.23%↓

LLY

732.88

+0.07%↑

JNJ

177.5

+0.27%↑

ABBV

211.68

+0.66%↑

UNH

308.79

-0.21%↓

NVO

56.36

-0.23%↓

LLY

732.88

+0.07%↑

JNJ

177.5

+0.27%↑

ABBV

211.68

+0.66%↑

UNH

308.79

-0.21%↓

NVO

56.36

-0.23%↓

LLY

732.88

+0.07%↑

JNJ

177.5

+0.27%↑

ABBV

211.68

+0.66%↑

UNH

308.79

-0.21%↓

NVO

56.36

-0.23%↓

Search

Evolent Health Inc

Gesloten

SectorGezondheidszorg

9.62 0.1

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

9.35

Max

9.75

Belangrijke statistieken

By Trading Economics

Inkomsten

14M

-51M

Verkoop

-39M

444M

Winstmarge

-11.498

Werknemers

4,500

EBITDA

43M

14M

Aanbevelingen

By TipRanks

Aanbevelingen

Strong Buy

12 Maanden Prognose

+64.66% upside

Dividenden

By Dow Jones

Volgende Winsten

6 nov 2025

Marktinformatie

By TradingEconomics

Marktkapitalisatie

-28M

1.1B

Vorige openingsprijs

9.52

Vorige sluitingsprijs

9.62

Nieuwssentiment

By Acuity

43%

57%

152 / 371 Rangschikking in Healthcare

Technische score

By Trading Central

Vertrouwen

Very Strong Bullish Evidence

Evolent Health Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

2 sep 2025, 23:07 UTC

Acquisities, Fusies, Overnames

Broadwood Partners Plans to Vote Against Staar Sale to Alcon

2 sep 2025, 22:10 UTC

Belangrijke Marktbewegers

Bruker Shares Fall on Convertible Share Offering Aimed at Debt Repayment

2 sep 2025, 21:47 UTC

Winsten

Alimentation Couche-Tard Logs Lower Profit, Revenue in 1Q

2 sep 2025, 16:52 UTC

Belangrijke Marktbewegers

CleanCore Solutions Shares Drop After $175 Million Private Investment

2 sep 2025, 22:47 UTC

Marktinformatie

Google, Apple Can Grow AI Deal With Lawsuit Resolved -- Market Talk

2 sep 2025, 21:40 UTC

Acquisities, Fusies, Overnames

Investors Have to Be Ready for State Capitalism. What Areas to Watch. -- Barrons.com

2 sep 2025, 21:07 UTC

Winsten

Couche-Tard 1Q U.S. Same-Store Merchandise Revenue Up 0.4% >ATD.T

2 sep 2025, 21:07 UTC

Winsten

Couche-Tard 1Q Canada Same-Store Merchandise Revenue Up 4.1% >ATD.T

2 sep 2025, 21:05 UTC

Winsten

Couche-Tard 1Q Rev $17.35B >ATD.T

2 sep 2025, 21:05 UTC

Winsten

Couche-Tard 1Q Adj EPS 78c >ATD.T

2 sep 2025, 21:05 UTC

Winsten

Couche-Tard 1Q EPS 82c >ATD.T

2 sep 2025, 21:05 UTC

Winsten

Couche-Tard 1Q Net $782.5M >ATD.T

2 sep 2025, 21:00 UTC

Marktinformatie

ESG Roundup: Market Talk

2 sep 2025, 20:53 UTC

Marktinformatie
Acquisities, Fusies, Overnames

Knight-Swift Transportation Endorses Union Pacific, Norfolk Southern Merger -- Market Talk

2 sep 2025, 20:51 UTC

Acquisities, Fusies, Overnames

Buffett Dislikes Breakup of Kraft Heinz. It's Been One of His Worst Investments. -- Barrons.com

2 sep 2025, 20:50 UTC

Marktinformatie

Basic Materials Roundup: Market Talk

2 sep 2025, 20:27 UTC

Winsten

NIO Stock Rises After Second-Quarter Loss Narrows -- Barrons.com

2 sep 2025, 20:24 UTC

Acquisities, Fusies, Overnames

Air Lease Is Going Private. Why Boeing Stock Is Up. -- Barrons.com

2 sep 2025, 20:18 UTC

Acquisities, Fusies, Overnames

Procter & Gamble Does Not Endorse Tutanota's Unsolicited Mini-Tender Offer >PG

2 sep 2025, 20:17 UTC

Acquisities, Fusies, Overnames

Procter & Gamble: Tutanota Says It Expects to Extend Offer for Successive Periods of Up to 180 Days Until Market Price Exceeds Offer Price >PG

2 sep 2025, 20:16 UTC

Acquisities, Fusies, Overnames

Procter & Gamble: 'Shareholders Who Tender Their Shrs in the Offer Will Receive a Below-Market Price' >PG

2 sep 2025, 20:16 UTC

Acquisities, Fusies, Overnames

Procter & Gamble: Offer by Tutanota Is to Purchase Up to 500,000 Shrs at $128 Each

2 sep 2025, 20:15 UTC

Acquisities, Fusies, Overnames

Procter & Gamble Has Been Notified of Unsolicited Mini-Tender Offer by Tutanota >PG

2 sep 2025, 19:55 UTC

Winsten

GM Had a Record Month of EV Sales. A 'Collapse' Is Coming. -- Barrons.com

2 sep 2025, 19:50 UTC

Acquisities, Fusies, Overnames

Food Giants Are Struggling. Could Mergers, Spinoffs, and Activist Stakes Help? -- Barrons.com

2 sep 2025, 19:09 UTC

Marktinformatie

Oil Futures Gain on Geopolitical Premium -- Market Talk

2 sep 2025, 19:00 UTC

Marktinformatie

U.S. Natural Gas Futures Recover $3 Level -- Market Talk

2 sep 2025, 18:12 UTC

Marktinformatie

Gold Pushes To New Record -- Market Talk

2 sep 2025, 17:04 UTC

Marktinformatie

Philip Morris Riding Smoke-Free Products to Higher Margins -- Market Talk

2 sep 2025, 16:57 UTC

Acquisities, Fusies, Overnames

Air Lease Is Going Private. Why Boeing Stock Is Up. -- Barrons.com

Peer Vergelijking

Prijswijziging

Evolent Health Inc Prognose

Koersdoel

By TipRanks

64.66% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 15.89 USD  64.66%

Hoogste 20 USD

Laagste 13 USD

Gebaseerd op 11 Wall Street-analisten die 12-maands prijsdoelen bieden voor Evolent Health Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Strong Buy

11 ratings

11

Buy

0

Hold

0

Sell

Technische score

By Trading Central

10.33 / 10.95Steun & Weerstand

Korte Termijn

Very Strong Bullish Evidence

Gemiddeld Termijn

Very Strong Bullish Evidence

Lange Termijn

Weak Bearish Evidence

Sentiment

By Acuity

152 / 371 Rangschikking in Gezondheidszorg

Nieuwssentiment

Bullish Bewijs

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Onder gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Evolent Health Inc

Evolent Health, Inc., through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company provides platform for health plan administration and value-based business infrastructure. It offers administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. In addition, the company provides holistic total cost of care management. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.